Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,588 | 26,768 | 17,671 | 15,211 | 23,151 |
| Receivables | 48,967 | 51,313 | 51,758 | 51,298 | 46,772 |
| Income taxes - deferred | 2,189 | 2,189 | 2,189 | 1,968 | 1,969 |
| Other current assets | 12,440 | 12,620 | 11,544 | 11,419 | 9,032 |
| TOTAL | $112,944 | $109,311 | $95,114 | $89,281 | $88,445 |
| Non-Current Assets | |||||
| PPE Net | 1,427,409 | 1,341,543 | 1,212,081 | 1,122,118 | 1,026,725 |
| Investments And Advances | 64,887 | 73,610 | 74,929 | 72,809 | 53,785 |
| Intangibles | 979 | 1,198 | 1,441 | 1,650 | 1,860 |
| Other Non-Current Assets | 9,763 | 10,018 | 4,376 | 0 | 1,142 |
| TOTAL | $1,503,038 | $1,426,369 | $1,292,827 | $1,196,577 | $1,083,512 |
| Total Assets | $1,615,982 | $1,535,680 | $1,387,941 | $1,285,858 | $1,171,957 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 68,280 | 67,830 | 61,044 | 39,387 | 30,887 |
| Accounts payable and accrued liabilities | 39,993 | 75,094 | 27,135 | 83,494 | 96,326 |
| Accrued Expenses | 8,633 | 4,254 | 8,465 | 9,253 | 7,927 |
| TOTAL | $125,883 | $156,991 | $106,779 | $143,388 | $147,613 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,067,488 | 970,949 | 888,990 | 825,687 | 580,643 |
| Deferred Revenues | 7,029 | 7,780 | 7,893 | 8,630 | 7,606 |
| Other Non-Current Liabilities | 0 | 0 | 0 | -238 | 99,487 |
| TOTAL | $1,109,551 | $1,015,660 | $934,317 | $865,275 | $745,433 |
| Total Liabilities | $1,235,434 | $1,172,651 | $1,041,096 | $1,008,663 | $893,046 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,179 | 22,144 | 22,055 | 19,295 | 19,295 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 201,695 | 184,764 | 168,697 | 151,286 | 134,758 |
| Other shareholders' equity | -3,907 | -4,096 | -2,917 | -3,273 | 15,363 |
| TOTAL | $380,548 | $363,029 | $346,845 | $277,195 | $278,911 |
| Total Liabilities And Equity | $1,615,982 | $1,535,680 | $1,387,941 | $1,285,858 | $1,171,957 |